Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma()()()

PURPOSE: We investigated the antitumor effect of the casein kinase II (CK2) inhibitor CX-4945 on cholangiocarcinoma (CCA). METHODS: We assessed the effect of CX-4945 alone and/or in combination with gemcitabine and cisplatin on cell viability, colony formation, and apoptosis of CCA cell lines and on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakharia, Kais, Miyabe, Katsuyuki, Wang, Yu, Wu, Dehai, Moser, Catherine D., Borad, Mitesh J., Roberts, Lewis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187100/
https://www.ncbi.nlm.nih.gov/pubmed/30316146
http://dx.doi.org/10.1016/j.tranon.2018.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187100/
https://www.ncbi.nlm.nih.gov/pubmed/30316146
http://dx.doi.org/10.1016/j.tranon.2018.09.005

Ejemplares similares